• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Hospitalization for IV Antibiotics Linked to Increased Complication Risks

by
November 18, 2026
in Health
Reading Time: 6 mins read
0
Hospitalization for IV Antibiotics Linked to Increased Complication Risks

Hospitalization for IV Antibiotics Linked to Increased Complication Risks

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A comprehensive systematic literature review published in Infectious Diseases and Therapy in November 2026 details the significant burden of hospital-acquired complications among patients receiving short-term intravenous antibiotics for bacterial infections. The study, led by Madison T. Preib and colleagues, evaluated two distinct systematic literature reviews to assess the prevalence of intravenous-line complications and the broader impact of hospitalization on patient outcomes. The research focused on patients treated with intravenous antibiotics for a duration of 30 days or less, a common clinical scenario for serious infections such as complicated urinary tract infections. The findings indicate that while hospitalization is a standard and often necessary practice for treating severe bacterial infections, it carries substantial risks of additional complications that prolong stays and increase healthcare costs.

The first systematic literature review, designated SLR1, specifically examined intravenous-line complications in patients with bacterial infections. The researchers identified 36 primary studies published between 2013 and 2023, encompassing a total sample size of 61,164 patients across various bacterial infections. In the overall population, the median prevalence of any intravenous-line complication was reported at 6.1%, with a wide range of 0.0% to 38.0% across the included studies. The most common specific complication was blockage or occlusion of the line, which had a median prevalence of 2.7%. For patients specifically diagnosed with complicated urinary tract infections, the median prevalence of any intravenous-line complication was lower, at 1.7%, likely reflecting the generally shorter duration of treatment required for this specific condition.

The incidence of these complications was also measured in terms of events per 1000 catheter or outpatient antimicrobial treatment days. The median incidence rate for any intravenous-line complication was 3.4 per 1000 days, with a 95% confidence interval ranging from 0.5 to 15.6. This rate varied by geography, with the highest median incidence observed in the United States at 3.6 per 1000 days, followed by Australia at 2.8 and the United Kingdom at 2.4. The type of catheter used also influenced the risk, with Hickman and Port catheters showing significantly lower incidence rates compared to peripherally inserted central catheters. Conversely, midline catheters were associated with a higher risk of complications compared to peripherally inserted central catheters, although findings across studies were inconsistent regarding this specific comparison.

A key finding from the first review was the comparison between patients who continued intravenous therapy and those who transitioned to oral antibiotics. In three of the four studies reporting data on any intravenous-line complication, the prevalence was significantly higher in the intravenous-only cohort compared to the intravenous-to-oral transition cohort. One study reported a hazard ratio of 0.08 for any intravenous-line complication in the transition cohort versus the intravenous-only cohort, indicating a 92% lower risk. This suggests that stepping down from intravenous to oral therapy, when clinically appropriate, may be an effective strategy to reduce the risk of line-related complications and the associated healthcare burden.

The second systematic literature review, SLR2, focused on the broader impact of hospitalization and the prevalence of hospital-acquired complications. This review included 36 primary studies and 9 systematic literature reviews, with a total sample size of 1,870,790 patients across all indications. The most common hospital-acquired complication in the overall population was falls, with a median prevalence of 11.5%. Hospital-acquired infections were the next most frequent, with a median prevalence of 4.2%. Specific infections such as Clostridioides difficile had a lower median prevalence of 0.4%, while methicillin-resistant Staphylococcus aureus infections had a median prevalence of 0.8%. In the subpopulation of patients with complicated urinary tract infections, the median prevalence of new infections was 5.4%, and Clostridioides difficile infections were reported in 0.2% of cases.

The duration of hospital stay was strongly associated with the risk of acquiring infections. The analysis revealed that each additional day in the hospital was associated with a 1.4% to 1.6% increase in the probability of developing a hospital-acquired infection. In one study, the predicted probability of acquiring an infection rose from 11.1% on day 2 to 20.6% on day 8. This temporal association highlights the cumulative risk of prolonged hospitalization. Furthermore, the presence of hospital-acquired complications significantly extended the length of stay. The additional hospital days attributable to these complications ranged from 0 to 28 days across the 12 studies that reported such data. This extension in stay not only affects patient recovery but also places a significant strain on hospital capacity and resources.

The economic impact of these complications is substantial. The review identified that hospital-acquired complications are associated with increased healthcare resource utilization, including readmissions, emergency department visits, and intensive care unit admissions. The mean total cost per case for treating any hospital-acquired infection was reported as USD $8,390, with direct costs averaging USD $5,449. For catheter-associated urinary tract infections, the mean per-patient cost was USD $17,285. The additional costs resulting from various hospital-acquired complications ranged widely from USD $876 to USD $160,804, depending on the severity of the complication and the patient population. These financial burdens are borne by both healthcare systems and patients, contributing to the overall cost of treating bacterial infections.

Mortality rates were also examined in relation to hospital-acquired complications. The review found that mortality rates in patients with these complications ranged from 2.1% to 35.0%, with a notably higher incidence compared to patients without complications. A meta-analysis included in the review reported that catheter-associated urinary tract infections were associated with more than three times higher mortality, with an odds ratio of 3.53. Similarly, patients with healthcare-associated bacteraemic urinary tract infections had a three-fold increase in the risk of 30-day mortality compared to those with community-acquired infections. In-hospital mortality was significantly higher in patients with hospital-acquired urinary tract infections, at 5.7%, compared to 2.6% in those without such infections.

The authors emphasize that the observed associations between hospitalization duration, complications, and outcomes should not be interpreted as evidence of a causal relationship. Residual confounding by factors such as illness severity, comorbidity burden, and exposure to invasive devices cannot be excluded. The temporal relationship may also be bidirectional, as longer hospitalization can increase the risk of complications, and complications can prolong hospitalization. Therefore, the findings should be viewed as associations rather than definitive causal links. Future research using more advanced statistical models is needed to fully understand the complex interplay between patient factors, hospitalization, and complications.

Limitations of the study include the restriction to English-language publications and the limited data on humanistic outcomes and quality of life. The reviews were conducted in 2023, so references published after that date were not included. Additionally, the heterogeneity across the included observational studies means that the findings may not be generalizable to all regions or patient populations. Despite these limitations, the review provides valuable insights into the risks associated with hospitalization for intravenous antibiotic therapy. The findings suggest that minimizing unnecessary intravenous exposure and hospital length of stay, when clinically feasible, could help reduce the occurrence of complications and the associated healthcare burden. This underscores the importance of individualized treatment decisions that balance clinical needs with the risks of prolonged hospitalization.

Detailed evaluations within outpatient parenteral antimicrobial therapy and targeted cohorts illuminated severe clinical events tied to line complications. In one study of patients experiencing catheter-related thrombosis during outpatient therapy, investigators documented pulmonary embolism in 10.6 percent of patients, while superior vena cava obstruction and haemorrhagic complications each occurred in 5.3 percent. Another outpatient investigation showed that 44.0 percent of individuals experiencing moderate or major catheter problems discontinued their therapy. Beyond these clinical events, intravenous-line complications required extensive healthcare resource utilisation. Across seven studies, rehospitalisation rates following line complications ranged from 0 to 100 percent, and intravenous-line replacement occurred in 18.8 to 100 percent of cases across four studies. Among patients with complicated urinary tract infections who experienced line complications, three of seven patients required rehospitalisation for catheter malfunctions or accidental removals, and one was rehospitalised due to vancomycin-resistant enterococcal bacteraemia.

The broader examination of hospitalization also identified specific risks related to extended inpatient care and post-discharge outcomes. In a study of trauma patients evaluating the hazards of prolonged hospitalisation after completion of acute medical care, each additional excess day was associated with a 5 percent increase in the odds of developing hospital-acquired complications. Furthermore, three studies tracking discharge outcomes documented 30-day hospital readmission rates ranging between 6.6 percent and 24.5 percent among patients who had sustained hospital-acquired complications. To evaluate the methodological integrity of the underlying literature, the researchers applied structured quality assessment instruments tailored to specific study designs. They employed the Newcastle-Ottawa Scale for observational cohort, case-control, and cross-sectional designs, the AMSTAR instrument for systematic reviews, the National Institute for Health and Care Excellence checklist for randomised controlled trials, and the Agency for Healthcare Research and Quality checklist for non-randomised and single-arm studies.

Subject of Research: Systematic Literature Review on the Impact of Hospitalisation and Associated Complications on Patients with Bacterial Infections Receiving Intravenous Antibiotics

Article Title: Systematic Literature Review on the Impact of Hospitalisation and Associated Complications on Patients with Bacterial Infections Receiving Intravenous Antibiotics

Article References: Preib, M. T., Kharawala, S., Malhotra, P., Svedsater, H., Drysdale, M., Chana, N., Farrell-Foster, A., & Mitrani-Gold, F. S. (2026). Systematic Literature Review on the Impact of Hospitalisation and Associated Complications on Patients with Bacterial Infections Receiving Intravenous Antibiotics. Infectious Diseases and Therapy. https://doi.org/10.1007/s40121-026-01471-9

Image Credits: AI Generated

DOI: 10.1007/s40121-026-01471-9

Keywords: Systematic, Literature, Review, Impact, Hospitalisation, Associated, Complications, Patients, Bacterial, Infections, Receiving, Intravenous, Antibiotics

News Source: Ophelia Keating. (November 18, 2026). Hospitalization for IV Antibiotics Linked to Increased Complication Risks. Scienmag.

Tags: antibioticsassociatedbacterialcomplicationshospitalisationimpactinfectionsIntravenousliteraturepatientsReceivingReviewSystematic
Share12Tweet7Share2ShareShareShare1

Related Posts

Archival Survey Reveals Complex Link Between Wetlands and Early Turkish Malaria

Archival Survey Reveals Complex Link Between Wetlands and Early Turkish Malaria

November 18, 2026
Workforce Planning Models for Older Adults Remain Severely Deficient in Eastern Mediterranean

Workforce Planning Models for Older Adults Remain Severely Deficient in Eastern Mediterranean

November 18, 2026

Mitochondrial Pore Therapeutics Advance Across Fifty Clinical Trials and Nanotechnology Platforms

November 18, 2026

Health Human Capital Drives Economic Growth in Lower-Middle-Income African Nations

November 18, 2026

POPULAR NEWS

  • Novel Wheat Gene TaRLK-1B Identified as Key Leaf Rust Defense Regulator

    Novel Wheat Gene TaRLK-1B Identified as Key Leaf Rust Defense Regulator

    29 shares
    Share 12 Tweet 7
  • Herbal Decoction Drives Molecular Rearrangement Into Chiral Nanoribbons That Aid Lipophagy

    29 shares
    Share 12 Tweet 7
  • Semi-Supervised Deep Learning Framework Detects Smart Grid Cyber Attacks With High Accuracy

    29 shares
    Share 12 Tweet 7
  • County Physical Inactivity Strongly Links to Youth Obesity Rates Across Tennessee

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Archival Survey Reveals Complex Link Between Wetlands and Early Turkish Malaria

Workforce Planning Models for Older Adults Remain Severely Deficient in Eastern Mediterranean

Mitochondrial Pore Therapeutics Advance Across Fifty Clinical Trials and Nanotechnology Platforms

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.